Skip to main content
Home
TERUMO GLOBAL

Select Region

Show — Select Region Hide — Select Region
    • Regions/Countries
        • Japan
        • United States
            • Terumo Interventional Systems
            • Terumo Cardiovascular
            • MicroVention (Neurovascular)
            • Terumo Blood and Cell Technologies
            • Terumo Aortic
            • Terumo Medical Products
            • Terumo Medical Corp
            • Terumo Health Outcomes
        • Canada
        • Europe
        • Latin America
            • Mexico
            • Brazil
            • Colombia
            • Chile and Argentina
            • Latin America
        • Asia Pacific
        • Australia
        • Korea
        • Vietnam
        • China
        • India
    • Global Business website
        • Terumo Cardiovascular
        • Terumo Aortic
        • MicroVention (Neurovascular)
        • Terumo Blood and Cell Technologies
        • Pharmaceutical Solutions
  • About Terumo
    About Terumo
      • Dear Stakeholders
      • Who We Are
      • Corporate Governance
      • Compliance
      • Regulations and Standards
      • Procurement Activity
      • At a Glance
      • Terumo Group Identity
      • Leadership Team
      • History
      • TERUMO’s Purpose
      • Terumo's Response to COVID-19
  • Business Overview
    Business Overview
      • TIS Division (Terumo Interventional Systems)
      • Neurovascular Division (MicroVention)
      • Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division
      • Vascular Graft Division (Terumo Aortic)
      • Hospital Care Solutions Division
      • Life Care Solutions Division
      • Pharmaceutical Solutions Division
      • Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
  • Sustainability
    Sustainability
      • Sustainability News
      • Message from Top Management
      • Sustainability at the Terumo Group
      • Resolving Healthcare Challenges
      • Creating a Diverse and Inclusive Workplace
      • Reducing Environmental Footprint
      • Serving Our Communities
      • Report Library
      • GRI Standards Index
  • Technology
    Technology
      • Basic Information
          • Basic Information Top
          • Research and Development
          • Production and Supply
          • Intellectual Property
          • Terumo Fellows
      • Stories - Our Technologies
  • Investors
    Investors
      • Management Policy
          • Management Policy
          • Top Management Message
          • Business Risks
          • Disclaimer
          • IR Policy
      • Financial Highlights
      • IR Library
          • IR Library
          • Financial Statements
          • Presentations
          • Consolidated Financial Statements
          • Terumo Reports
      • IR Events
      • Shareholders & Stock
          • Shareholders Meeting
          • Stock Information
          • Shareholder Return
          • Credit Ratings and Corporate Bond
          • Analyst Coverage
          • Articles of Incorporation
          • Site Quote
      • IR Inquiries
  • News
    News
      • March 07, 2023
        Corporate
        Terumo Prospective Registry Reinforces Safety, Efficacy and Efficiency of Radial Access in Visceral Interventions (R.A.V.I.) in Embolization Procedures

        Findings show intra-vascular access via the radial artery can successfully be used as the primary strategy for the modern embolization practice

      • March 02, 2023
        Corporate
        Terumo to Further Drive DE&I by Establishing Focus Areas to Commit Globally
      • February 23, 2023
        Corporate
        Terumo Blood and Cell Technologies Presents First Quantum Flex Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose

        Presentation at CAR-TCR Summit Europe demonstrates scalability and reduced media usage enable lower cost to produce a dose of autologous T-cell therapy

    • Global Network
      Global Network
        • Japan
        • North America
        • South America
        • Europe, Middle East and Africa
        • Greater China
        • Asia and Pacific

    Breadcrumb

    1. Home
    2. Investors
    3. IR Library

    IR Library

    Move to topTop
    The Latest Materials
    • 3rd Quarter Financial Results for FYE 3/2023
      February 09, 2023
      Financial Statements
      IFRS Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023 (PDF 383.66 KB)
      Presentation Material
      Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2023 (FY2022) (PDF 1.28 MB)
      Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2023 (FY2022)(with note) (PDF 947.34 KB)
      Additional Information
      Revenue by Segment (PDF 162.23 KB)
      Revenue by Segment (Excel 119.69 KB)
      Q&A
      Q&A Session at the Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2023 (FY2022) (PDF 136.84 KB)
      Webcast
      Listen to the Webcast
    Financial Statements
    /investors/library/financial-statements
    Presentations
    /investors/library/presentations
    Terumo Report
    /investors/library/annual-reports
    Sustainability
    /sustainability
    Corporate Governance
    /about/governance
    Consolidated Financial Statements
    /investors/library/financial

    Adobe Reader is required for viewing PDF files.

    Download Adobe Reader

    Footer Menu

    Show — Footer Menu Hide — Footer Menu
      • About Terumo
          • About Terumo
          • Dear Stakeholders
          • Who We Are
          • Corporate Governance
          • Compliance
          • Regulations and Standards
          • Procurement Activity
          • At a Glance
          • Terumo Group Identity
          • Leadership Team
          • History
          • TERUMO’s Purpose
          • Terumo's Response to COVID-19
      • Business Overview
          • Business Overview
          • TIS Division (Terumo Interventional Systems)
          • Neurovascular Division (MicroVention)
          • Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division
          • Vascular Graft Division (Terumo Aortic)
          • Hospital Care Solutions Division
          • Life Care Solutions Division
          • Pharmaceutical Solutions Division
          • Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
      • Sustainability
          • Sustainability Overview
          • Sustainability News
          • Message from Top Management
          • Sustainability at the Terumo Group
          • Resolving Healthcare Challenges
          • Creating a Diverse and Inclusive Workplace
          • Reducing Environmental Footprint
          • Serving Our Communities
          • Report Library
          • GRI Standards Index
      • Technology
          • Technology Overview
          • Basic Information
              • Research and Development
              • Production and Supply
              • Intellectual Property
              • Terumo Fellows
          • Stories - Our Technologies
      • Investors
          • Investors
          • Management Policy
              • Top Management Message
              • Business Risks
              • Disclaimer
              • IR Policy
          • Financial Highlights
          • IR Library
              • Financial Statements
              • Presentations
              • Consolidated Financial Statements
              • Terumo Reports
          • IR Events
          • Shareholders & Stock
              • Shareholders Meeting
              • Stock Information
              • Shareholder Return
              • Credit Ratings and Corporate Bond
              • Analyst Coverage
              • Articles of Incorporation
              • Site Quote
          • IR Inquiries
      • News
          • News
          • Press Inquiries
      • Global Network
          • Japan
          • North America
          • South America
          • Europe, Middle East and Africa
          • Greater China
          • Asia and Pacific
    • About Terumo
    • Business Overview
    • Sustainability
    • Technology
    • Investors
    • News
    • Global Network

    Footer

    Show — Footer Hide — Footer
    • Terms and Conditions of Use
    • Privacy Policy
    • Cookie Policy
    • Cookie Settings
    • Social Media Policy
    • Site Map

    Copyright © 2023 Terumo Corporation, All Rights Reserved.